Author

György Timár

Observed names: G Tímár, G. Tímár, György Tímár

Institution: Syreon Research Institute (Hungary)

Observed institution: Syreon Research Institute (Hungary)

OpenAlex ID: A5000669196

The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids

2014 · Balázs Nagy, György Timár, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 14

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

2025 · Zoltán Kaló, Attila Imre, et al. · British Journal of Clinical Pharmacology · 1

PIH24 Economic Evaluation of Ulipristal Acetate Tablets for the Treatment of Patients with Moderate and Severe Symptoms of Uterine Fibroids

2012 · B. Nagy, G. Tímár, et al. · Value in Health · 1

Early cost-effectiveness analysis of the U-Care Renal Platform

2026 · Attila Imre, György Tímár, et al. · BMC Nephrology

Prs16 Pitfalls in Therapeutic Reference Pricing Practice of the Medication of Asthma

2010 · Z Kalo, Z Abonyi-Tóth, et al. · Value in Health

Works count: 5

Citation count: 16

H-index: 1

I10-index: 1